Hogan Lovells advises Villaris Therapeutics in US$70 million acquisition for vitiligo antibody

Advising firms

The announcement does not name individual lawyers.

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value

USD 70m (US$70 million)

What the figure measures

Total transaction value

Client

Villaris TherapeuticsSell-side

Counterparties

Incyte (Buy-side)